Hydroxyethyl cyclosporin A induces and decreases P4503A and P-glycoprotein levels in rat liver

Xenobiotica

Volumn 26, Issue 1, 1996, Pages 27-39

  Vickers, A E M ^a   Alegret, M ^a   Meyer, E ^a   Smiley, S ^a   Guertler, J ^a  

^a Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A [8 DEXTRO O (2 HYDROXYETHYL)SERINE]; CYCLOSPORIN DERIVATIVE; CYTOCHROME P450 ISOENZYME; GLYCOPROTEIN P; HYDROXYETHYL CYCLOSPORIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME INDUCTION; ENZYME INHIBITION; KIDNEY; LIVER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0029936552     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046686     Document Type: Article

References (34)

1. AUGUSTINE, J. A., and ZEMAITIS, M. A., 1986, The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat. Drug Metabolism and Disposition, 14, 73-78.
2. AUGUSTINE, J. A., and ZEMAITIS, M. A., 1989, A comparison of the effects of cyclosporine (CSA) on hepatic microsomal drug metabolism in three different strains of rat. General Pharmacology, 20, 137-141.
3. BAUMANN, G., ANDERSEN, E., QUESNIAUX, V., and EBERLE, M. K., 1992, Cyclosporine and its analogue SDZ IMM 125 mediate very similar effects on T-cell activation. A comparative analysis in vitro. Transplantation Proceedings, 24, 43-48.
4. BERTRAULT-PERES, P., BONFILS, C., FABRE, G., JUST, S., CANO, J. P., and MAUREL, P., 1987, Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Drug Metabolism and Disposition, 15, 391-398.
5. BRUELISAUER, A., KAWAI, R., MISSLIN, P., and LEMAIRE, M., 1994, Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration. Drug Metabolism and Disposition, 22, 194-199.
6. CARROLL, M. A., QUILLEY, C. P., and MCGIFF, J. C., 1991, Novel arachidonate metabolites generated by cytochrome P450-dependent mono-oxigenases. Pharmacology Research, 23, 309-318.
7. CHAN, H. S. L., THORNER, P. S., HADDAD, G., and LING, Y., 1990, Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. Journal of Clinical Oncology, 8, 689-704.
8. CHEN, Y. L., LE VRAUX, V., LENEVEU, A., DREYFUS, F., STHENEUR, A., FLORENTIN, I., DE SOUSA, M., GIROUD, J. P., FLOUVAT, B., and CHAUVELOT-MOACHON, L., 1994, Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clinical Pharmacology and Therapeutics, 55, 649-660.
9. COMBALBERT, J., FABRE, I., FABRE, G., DALET, I., DERANCOURT, J., CANO, J. P., and MAUREL, P., 1989, Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metabolism and Disposition, 34, 197-207.
10. CUNNINGHAM, C., WHITING, P. H., BURKE, M. D., WHEATLEY, D. N., and SIMPSON, J. G., 1983, Increasing the hepatic metabolism of cyclosporin abolishes nephrotoxicity. Transplantation Proceedings, 15 (suppl. 1), 2712-2715.
11. CUNNINGHAM, C., BURKE, M. D., WHEATHLEY, D. N., THOMSON, A. W., SIMPSON, J. G., and WHITING, P. H., 1985, Amelioration of cyclosporin-induced nephrotoxicity in rats by induction of hepatic drug metabolism. Biochemical Pharmacology, 34, 573-578.
12. FABRE, J. M., PEDROSA, R., BONARDET, A., PICHARD, L., DESCOMPS, B., DOMERGUE, J., BAUMEL, H., and MAUREL, P., 1993, Metabolism of cyclosporine after orthotopic liver transplantation. Biochemical Pharmacology, 46, 1151-1157.
13. FOXWELL, B. M. J., MACKIE, A., LING, V., and RYFFEL, B., 1989, Identification of the multidrug resistance-related P-glycoprotein as a cyclosporin binding protein. Molecular Pharmacology, 36, 543-546.
14. GANT, T. W., SILVERMAN, J. A., BISGAARD, H. A., BURT, R. K., MARINO, P. A., and THORGEIRSSON, S. S. 1991, Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver. Molecular Carcinogenesis, 4, 499-509.
15. ISOGAI, M., SHIMADA, N., KAMATAKI, T., IMAOKA, S., and FUNAE, Y., 1993, Changes in the amounts of cytochromes P450 in rat hepatic microsomes produced by cyclosporin A. Xenobiotica, 23, 799-807.
16. KRONBACH, T., FISCHER, V., and MEYER, U. A., 1988, Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology and Therapeutics, 43, 630-635.
17. LAKE, B. G., 1987, Preparation and characterization of microsomal fractions for studies of xenobiotic metabolism. In Biochemical Toxicology, A Practical Approach, edited by K. Snell and B. Mullock (IRL: Oxford), pp. 183-216.
18. LUCEY, M. R., KOLARS, J. C., MERION, R. M., CAMPBELL, D. A., ALDRICH, M., and WATKINS, P. B., 1990, Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet, 335, 11-15.
19. MACHKOVA, Z., MOSTECKA, H., SEIFERT, J., and MASEK, K., 1991, The effect of cyclosporine A on renal and hepatic microsomal mixed function oxidase systems in rats. Methods and Findings in Experimental and Clinical Pharmacology, 12, 239-244.
20. MAYER, R. D., BERMAN, S., COCKETT, A. T., and MAINES, M. D., 1989, Differential effects of cyclosporin on hepatic and renal heme, cytochrome P-450 and drug metabolism. Biochemical Pharmacology, 38, 1001-1007.
21. MCGIFF, J. C., 1991, Cytochrome P-450 metabolism of arachidonic acid. Annual Reviews of Pharmacology and Toxicology, 31, 339-369.
22. MOOCHHALA, S. M., and RENTON, K. W., 1986, Inhibition of hepatic microsomal drug metabolism by the immunosuppressive agent cyclosporin A, Biochemical Pharmacology, 35, 1499-1503.
23. NAKAMURA, M., IMAOKA, S., MIURA, K., TANAKA, E., MISAWA, S., and FUNAE, Y., 1994, Induction of cytochrome P450 isozymes in rat renal microsomes by cyclosporin A. Biochemical Pharmacology, 48, 1743-1746.
24. PRUEKSARITANONT, T., ALMIRA CORREIA, M., RETTIE, A. E., SWINNEY, D. C., THOMAS, P. E., and BENET, L. Z., 1993, Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzymes other than cytochromes P-450 3A. Drug Metabolism and Disposition, 21, 730-737.
25. RIFKIND, A. B., GANNON, M., and GROSS, S. S., 1990, Arachidonic acid metabolism by dioxin-induced cytochrome P450: a new hypothesis on the role of P-450 in dioxin toxicity. Biochemical and Biophysical Research Communications, 172, 1180-1188.
26. SACERDOTI, D., BORSATO, M., RIGOTTI, P., AMODIO, P., ANGELI, P., FERRARESSO, M., PLEBANI, M., and GATTA, A., 1991, Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity. In Prostaglandins and Related Compounds, 7th International Conference, Florence, Italy, 28 May-1 June 1990, edited by B. Samuelsson, P. W. Ramwell, R. Paoletti, G. Folco and E. Granstrom (Raven: New York), pp. 689-692.
27. SADRIEH, N., GHOSAL, A., and THOMAS, P. E., 1993. In vivo effects of cyclosporine A on hepatic and renal drug metabolizing enzymes. The Toxicologist, 13, 1343.
28. SAEKI, T., UEDA, K., TANIGAWARA, Y., HORI, R., and KOMANO, T., 1993, Human P-glycoprotein transports cyclosporin A and FK506. Journal of Biological Chemistry, 268, 6077-6080.
29. SHARMA, R. K., DOIG, M. V., LEWIS, D. F., and GIBSON, G. G., 1989, Role of hepatic and renal cytochrome P-450 IVA1 in the metabolism of lipid substrates. Biochemical Pharmacology, 38, 3621-3629.
30. THORGEIRSSON, S. S., SILVERMAN, J. A., GANT, T. W., and MARINO, P. A., 1991, Multidrug resistance gene family and chemical carcinogens. Pharmacology and Therapeutics, 49, 283-292.
31. VICKERS, A. E. M., MEYER, E., DANNECKER, R., KELLER, B., TYNES, R. E., and MAURER, G., 1995, Human liver cytochrome P4503 A biotransformation of the cyclosporin derivative SDZ IMM 125. Drug Metabolism and Disposition, 23, 321-326.
32. VINCENT, S. H., WANG, R. W., KARANAM, B. V., KLIMKO, M., ALVARO, R., and CHIU, S-HL., 1991, Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase. Biochemical Pharmacology, 41, 1325-1330.
33. WAGNER, O., SCHREIBER, E., HEITZ, F., and MAURER, G., 1987, Tissue distribution, disposition and metabolism of cyclosporine in rats. Drug Metabolism and Disposition, 15, 377-383.
34. YOSHIMURA, R., YOSHIMURA, N., NAKATANI, T., KUSUNOSE, E., YAMAGUCHI, T., OKA, T., and KISHIMOTO, T., 1993, The effects of cyclosporin on renal microsomal cytochrome P-450 systems. Clinical Nephrology, 40, 339-345.